Renin-angiotensin-aldosterone system has a pivotal role in cognitive impairment (Q38108717)

29 August 2017

title

Renin-angiotensin-aldosterone system has a pivotal role in cognitive impairment (English)

1 reference

29 August 2017

main subject

cognitive dysfunction

1 reference

Shusuke Yagi

1

1 reference

29 August 2017

Masashi Akaike

2

1 reference

29 August 2017

Takayuki Ise

3

1 reference

29 August 2017

Yuka Ueda

4

1 reference

29 August 2017

Takashi Iwase

5

1 reference

29 August 2017

Masataka Sata

6

1 reference

29 August 2017

publication date

23 May 2013

1 reference

29 August 2017

published in

Hypertension Research

1 reference

29 August 2017

volume

36

1 reference

29 August 2017

issue

9

1 reference

29 August 2017

page(s)

753-758

1 reference

Cognitive dysfunction and physical disability are associated with mortality in extremely elderly patients

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Cerebral perfusion as a diagnostic marker of early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Essential hypertension and cognitive function. The role of hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

The relationship between blood pressure and cognitive performance in the Third National Health and Nutrition Examination Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Blood pressure and cognitive function in an African-American and a Caucasian-American sample: the Maine-Syracuse Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

The role of blood pressure in cognitive impairment in an elderly population. Osservatorio Geriatrico Campano Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Blood pressure-related cognitive decline: does age make a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Blood pressure and performance on the Mini-Mental State Examination in the very old. Cross-sectional and longitudinal data from the Kungsholmen Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Cognitive impairment and risk of cardiovascular events and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

The angiotensin receptor subtype AT1A predominates in rat forebrain areas involved in blood pressure, body fluid homeostasis and neuroendocrine control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Angiotensin II in central nervous system physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Use of ramipril in preventing stroke: double blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Multiple cellular and molecular mechanisms are involved in human Aβ clearance by transplanted adult astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Brain renin angiotensin in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Direct stimulation of angiotensin II type 2 receptor enhances spatial memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

The CNS renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

The Role of Blood Pressure and Aldosterone in the Production of Hemorrhagic Stroke in Captopril-Treated Hypertensive Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Pathophysiological effects of aldosterone in cardiovascular tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Improvement of cognitive impairment in female type 2 diabetes mellitus mice by spironolactone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Renin-angiotensin system in the brain as a new target of antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Neurological protection provided by candesartan: reviewing the latest study results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Critical role of angiotensin II in excess salt-induced brain oxidative stress of stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Brain penetration of telmisartan, a unique centrally acting angiotensin II type 1 receptor blocker, studied by PET in conscious rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Telmisartan protects against cognitive decline via up-regulation of brain-derived neurotrophic factor/tropomyosin-related kinase B in hippocampus of hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Effect of the angiotensin II type 1 receptor antagonist olmesartan on cerebral hemodynamics and rehabilitation outcomes in hypertensive post-stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Binding of angiotensin antagonists to rat liver and brain membranes measured ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Influence of losartan and atenolol on memory function in very elderly hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Inhibition of brain angiotensin-converting enzyme by peripheral administration of trandolapril versus lisinopril in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Captopril and enalapril improve cognition and depressed mood in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Post-stroke treatment with imidapril reduces learning deficits with less formation of brain oedema in a stroke-prone substrain of spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

Cognitive function and the emotional state of stroke patients on antihypertensive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

15-year longitudinal study of blood pressure and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

7 January 2021

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

7 January 2021

Blood pressure and cognitive function in healthy old people

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

7 January 2021

Hypertension and dementia

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

7 January 2021

Impact of Angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

7 January 2021

Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

7 January 2021

Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

7 January 2021

Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2013.51

7 January 2021

Identifiers

DOI

10.1038/HR.2013.51

1 reference

Dimensions Publication ID

29 August 2017

1004399437

0 references

1 reference